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ABSTRACT
The aim of the present work is to develop nanoemulsions (NEs), nanosized emulsions, manufactured for
improving the delivery of active pharmaceutical ingredients. In particular, nanoemulsions composed of
Neem seed oil, contain rich bioactive components, and Tween 20 as nonionic surfactant were prepared.
A mean droplet size ranging from 10 to 100nm was obtained by modulating the oil/surfactant ratio.
Physicochemical characterisation was carried out evaluating size, f-potential, microviscosity, polarity and
turbidity of the external shell and morphology, along with stability in simulated cerebrospinal fluid (CSF),
activity of Neem oil alone and in NEs, HEp-2 cell interaction and cytotoxicity studies. This study confirms
the formation of NEs by Tween 20 and Neem oil at different weight ratios with small and homogenous
dimensions. The antioxidant activity of Neem oil alone and in NEs was comparable, whereas its cytotoxicity
was strongly reduced when loaded in NEs after interaction with HEp-2 cells.
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According to the European Commission definition, nanotechnol-
ogy is a branch of engineering devoted to designing, producing
and using structures and devices having one or more dimensions
of about 100 nanometres or less. Nanoscience and nanotechnol-
ogy are the study and application of extremely small things and
can be used across all the other science fields, such as chemistry,
biology, physics, materials science, engineering and in
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pharmaceutical sector. New or extensively used drugs can be bet-
ter formulated if loaded in specific nanocarriers in order to over-
come problems such as low solubility, large biodistribution, low
bioavailability, adverse effects, high costs and so on. Along the
diverse nanocarriers that are widely used in pharmaceutics, nanoe-
mulsions have attracted great attention in drug delivery and
pharmacotherapy. In particular, nanoemulsions act as an excellent
and versatile vehicle for poorly aqueous soluble drugs, which are
otherwise difficult to formulate in conventional dosage forms.
Nanoemulsions are submicron emulsions composed of generally
recognized as safe (GRAS) grade excipients approved by the
United States Food and Drug Administration (FDA) and with the
possibility to use different oils that can modulate the drug activity.
Nanoemulsions are easily produced in large quantities by high
shear stress or mechanical extrusion process and can be engi-
neered with specific attributes such as size, surface charge, pro-
longed blood circulation and targeting properties. Nanoemulsions
can be prepared in order to tune their physicochemical properties
to be applied in therapy, diagnostics or theranostics.
The size of the droplets varies depending on the drug particles,
mechanical energy, composition and relative amount of the surfac-
tants1. Nanoemulsions are also known as miniemulsions, fine-dis-
persed emulsions, submicron emulsions, etc., which can be either
oil in water (O/W) or water in oil (W/O) emulsion. The amount of
oil in O/W nanoemulsions may vary but generally is within 5–20%
w/w. Sometimes a mixture of oils may be used to improve drug
solubilisation in the oil phase. A co-surfactant or a co-solvent may
be used in addition to the surfactant to facilitate the stabilisation
process2,3. The significant property that differentiates the nanoe-
mulsions from other emulsion systems is that a nanoemulsion
shows a different pattern in physical and rheological properties
with decreasing droplet size. Nanoemulsion is much more stable
than other emulsion systems and is more translucent compared to
microemulsions4. Few nanoemulsions have been manufactured
commercially in oral, topical, ophthalmic and even in intravenous
(IV) drug delivery system. IV administration of nanoemulsions
requires biodegradable surfactants. Numerous researches are pres-
ently being carried out in order to manufacture nanoemulsions
from different classes of drugs for a variety of purposes. The use
of nanoemulsions spreads from antibiotic therapy, atherosclerosis
treatment, transdermal drug delivery and ophthalmic application
to as far as cancer therapy, vaccine delivery, etc5–7.
One of the most appealing challenges in nanotechnology is to
find an opportune strategy to bypass blood–brain barrier (BBB)
and to reach the central nervous system (CNS). Among the numer-
ous approaches proposed, the direct nose-to-brain drug delivery is
a potential strategy to overcome the obstacles presented by the
BBB. Intranasal delivery bypasses the BBB to target CNS, reducing
systemic exposure of drug, thereby reducing the systemic side
effects. It is an attractive option of drug delivery due to its
noninvasiveness8–10.
Moreover, several researches suggest that the “nose-to-brain”
route is one of the most important developments of
pharmaceutical research in brain treatment, including the follow-
ing: (i) the potential to avoid gastrointestinal (GI) and hepatic first-
pass metabolism; (ii) the possibility of delivering drugs not suitable
for oral administration, such as peptides and proteins; and (iii)
most importantly, the transport of exogenous material directly
from the nasal cavity to the brain, thus bypassing the BBB11.
It is still unknown whether the drug is being released from the
carrier system in the nasal cavity and transported to CNS, or the
carrier system is transported along olfactory and/or trigeminal
nerve pathways into the CNS where the drug is released. Thus,
more basic research is required to determine the possible trans-
port pathway of therapeutic carrier to the CNS and their further
fate into the biological system8.
In addition to the vesicular systems, widely used in nasal
administration, other carriers are able to encapsulate drug and to
perform intranasal delivery to CNS, such as cyclodextrins, micro-
and nanoemulsions and nanoparticles11.
Nanoemulsions, by virtue of their lipophilic nature and low
globule size, are widely explored as a delivery system to enhance
uptake across the nasal mucosa. The possibility of using mucoad-
hesive agents such as polyelectrolyte polymers can prolong the
nasal mucosa interaction, providing an extended delivery of the
drug to the olfactory region and henceforth to the brain8.
The aim of this research study was to prepare and characterise a
functional O/W nanoemulsion by using Neem oil. Neem oil is a
deep yellow extract from Azadirachta indica A. Juss. (Meliaceae)
seeds widely used in India and in other South-East countries as ver-
satile medicinal product for several diseases, as pesticide/insecticide,
and in cosmetics due to its low toxicity in in vivo studies12. These
pharmaceutical properties are correlated with the content of limo-
noids (e.g. azadirachtin) as the most bioactive metabolites13. In this
study, we made an effort to prepare nanoemulsions from Neem
seed oil. We used Tween 20 as a nonionic surfactant because non-
ionic surfactants are known to be less affected by pH14,15. The aim
was to prepare NEs with the possibility of combining, in a future
study, the pharmacological properties of Neem oil and those of the
therapeutic agent targeted by nanoemulsion.
Materials and methods
Materials
Neem oil was purchased by Neem Italia (Moniga del Garda (BS),
Italy) and is characterised by an ECOCERT certificate (Biocert Italia
IT013BC041 – ICEA 264BC001). Tween 20 (Tw20), Hepes salt {N-(2-
hydroxyethyl) piperazine-N-(2-ethanesulphonic acid)} and pyrene
were Sigma-Aldrich products (Sigma-Aldrich, Milan, Italy). Distilled
water (Ecological Product System s.r.l., Rome, Italy) was used for all
experiments. All other products and reagents were of analytical
grade.
Nanoemulsion preparation
Nanoemulsions (NEs) were prepared using different amounts of
Tw20 and Neem oil (Table 1) in different weight ratios. Tw20
Table 1. Sample compositions, size, f-potential, PDI values and lipophilic shell features (polarity and microviscosity) of NEs.
Samples Medium Noil (%w/w) Tw20 (%w/w) HD (nm) ± SD f-Pot (mV) ± SD PDI ± SD Polarity (AU) ± SD MicroV (AU) ± SD
A1 Water 33.3 66.6 30.98 ± 0.49 7.29 ± 1.54 0.20 ± 0.01 0.97 ± 0.01 1.18 ± 0.02
A2 Hepes 30.47 ± 0.28 16.80 ± 1.22 0.23 ± 0.01 0.94 ± 0.02 1.19 ± 0.01
B1 Water 20.0 80.0 21.73 ± 0.30 6.35 ± 1.87 0.22 ± 0.01 0.97 ± 0.01 1.22 ± 0.03
B2 Hepes 22.62 ± 0.23 13.80 ± 1.40 0.24 ± 0.01 0.97 ± 0.01 1.22 ± 0.01
C1 Water 12.4 83.6 15.42 ± 0.11 5.45 ± 0.21 0.18 ± 0.01 0.97 ± 0.01 1.21 ± 0.02
C2 Hepes 16.76 ± 0.27 15.00 ± 1.79 0.22 ± 0.01 0.96 ± 0.01 1.21 ± 0.01
NE samples were prepared using two different aqueous media: water and Hepes buffer (102M pH 7.4).
Noil: Neem oil; Tw20: Tween 20; HD: hydrodynamic diameter; f-Pot: f-potential; MicroV: microviscosity.
Results are expressed as means ± SD (n¼ 3).






























concentration in the samples was always remarkably above CMC
(0.048mM in water, at 20 C).
Where indicated, the fluorescent probe pyrene (4mM) was
added to the surfactant/oil mixture before NE preparation. The NEs
were obtained by a simple preparation method, as previously
reported16. Neem oil, Tw20 and distilled water, or Hepes buffer
(102M, pH 7.4) where indicated, were used in the preparation of
water-based (O/W) emulsion. The emulsions contained Neem oil
and surfactant with ratios of 1:2, 1:4 and 1:7, respectively. To form
the emulsion, the two phases were vortexed for about 5min. Each
emulsion with microscale droplets was sonicated for 20min at
50 C using a tapered microtip operating at 20 kHz at an amplitude
of 18% (Vibracell-VCX 400, Sonics, Taunton, MA) to obtain NEs.
Dynamic light scattering measurements
Dynamic light scattering (DLS) on a Malvern Zetasizer Nano ZS90
(Malvern Instruments Ltd., Worcestershire, United Kingdom) was
used to measure the size and the f-potential of the NEs allowing
to determine the mass distribution of particle size as well as the
dispersed particle electrophoretic mobility. Obtained data repre-
sent means of the measurements of f-potential (mV) and of the
hydrodynamic diameter (nm) for the NE droplets. It is important
to notice that size distribution results are expressed as % of inten-
sity of the colloidal dispersion. The polydispersity index (PDI) value
was also determined as an evaluation of the breadth of the size
distribution: a PDI value lower than 0.3 indicates a homogenous
and monodisperse population.
Lipophilic shell characterisation
The fluorescence experiments on NEs incorporating pyrene were
carried out to evaluate the micropolarity of the lipophilic shell sur-
rounding the oil droplet by a Perkin-Elmer LS55 spectrofluorome-
ter. Using the pyrene probe, which is entrapped mainly in the
lipophilic shell, it is possible to investigate the lateral distribution
and the dynamics of membrane compounds. Pyrene is a spatially
sensitive probe, displaying a peculiar band around 460 nm when
two molecules are spatially proximal (excimer); it is worthy to
notice that when the excimer fluorescence decreases, there is an
increase in monomer fluorescence. The monomer and the excimer
possess different fluorescent signals and by evaluating the ratio of
the fluorescence intensities is possible to understand the probe
distribution in the lipid network. The pyrene monomer fluorescent
spectrum consists of five peaks. It is well established that the ratio
I1/I3 between the intensities of the first (I1) and third (I3) vibration
bands of the pyrene fluorescence spectrum (corresponding to
372 nm and 382 nm, respectively) is related to the polarity of the
pyrene environment. Low values of the I1/I3 ratio correspond to a
nonpolar environment. This ratio increases as the polarity of the
medium rises17. Since pyrene is solubilised inside the hydrocarbon
chain of the NE shell, the information obtained from fluorescence
of pyrene in our systems refers to the lipophilic shell of NE
pigeonhole18. The presence of pyrene intramolecular excimers
depends on the rate of conformational change of the molecule,
which is sensitive to the viscosity of the probe microenviron-
ment19. Hence, the IE/IM ratio, where IM and IE stand for the
intensity of the monomer and the excimer fluorescence, respect-
ively, is used to estimate the microviscosity. Because of its high
hydrophobicity, the solubilisation zone of pyrene occurs in the lipi-
dic shell, as was established in the case of polymeric micellar solu-
tions20. The pyrene probe may also evidence (only qualitatively)
the micropolarity variation in the solubilisation region, by the
change in the ratio of monomer vibronic band intensities meas-
ured at 377 nm and 397 nm21.
Physicochemical stability
Specific studies on physical stability of NEs, composed of Tw20
and Neem oil at different ratios, were carried out to investigate
whether significant size and f-potential changes in NE dispersion
occur during storage at the two selected temperatures, using
water or Hepes buffer as aqueous phase. The NEs were stored at 4
and 25 C for a period of 90 days. Samples were analysed at defin-
ite time intervals (1, 30, 60 and 90 days) and the f-potential and
the mean of hydrodynamic diameter of vesicles were measured as
previously described.
Biological studies were carried out in the presence of simulated
cerebrospinal fluid (CSF), pH 7.3, to evaluate the stability of NE if
administered nasally. The CSF was prepared as described by
McNay et al.22. NEs were diluted in CSF to obtain a final CSF con-
centration of 45% in Hepes buffer (pH 7.4, 10mM). The average
size, polydispersity index and f-potential were evaluated at differ-
ent time points (30, 60, 120 and 180min) at 37 C.
Small angle X-ray scattering (SAXS)
Small angle X-ray scattering (SAXS) experiments were carried out
at the European Synchrotron Radiation Facility (ESRF, Grenoble,
France). Measurements were acquired at the high-brilliance beam-
line ID02, with two sample-detector distances, in the region of
momentum transfer 0.017 nm1 q 5 nm1 (q¼ (4p/k) sin(h/2),
where h is the scattering angle). Samples were inserted in 2mm
capillaries (KI-beam, ENKI, Concesio, Italy) and placed horizontally
onto a thermostatted sample holder (T¼ 25± 0.1 C). Very shorts
frames were collected (exposure time 0.1 s) and checked for effects
induced by radiation damage before be averaged. After radial
integration and background subtraction, the SAXS profiles report
the scattered radiation intensity as a function of momentum trans-
fer, q. The intensity decay behaviour can give information on the
structure of the particles in solution on the nanometre length
scale. Synchrotron small-angle X-ray scattering (SAXS) techniques
can give information on the internal structure of formulations for
drug delivery23,24.
Transmission electron microscopy (TEM)
Ten microlitres of diluted samples was adsorbed for 1min onto
Formvar-coated copper grids, then negatively stained with 2% fil-
tered aqueous sodium phosphotungstate adjusted to pH 7.0.
Negatively stained preparations were observed by a Philips 208 S
transmission electron microscope (Philips Electron Optics,
Eindhoven, The Netherlands) at 80 kV.
Radical scavenging activity
Free radical scavenging activity (DPPH)
Test solution (1ml) was added to DPPH solution (4ml, 0.004%
methanolic solution). The sample absorbance was noted at 517 nm
after 30-min incubation at room temperature in the darkness.
Results were expressed as milligrams of Trolox equivalents per
sample amount (mg TEs)25.
ABTS (2,2 azino-bis (3-ethylbenzothiazoline-6-sulphonic acid)) rad-
ical cation scavenging activity
ABTSþ radical cation was produced directly by reacting 7mM
ABTS solution with 2.45mM potassium persulphate and allowing






























the mixture to stand for 12–16 h in the darkness at the room tem-
perature. Firstly, ABTS solution was diluted with methanol to an
absorbance of 0.70 ± 0.02 at 734 nm. Test solution (1ml) was
mixed with ABTS solution (2ml) and mixed. The sample absorb-
ance was noted at 734 nm after 30-min incubation at room tem-
perature. Results were expressed as milligrams of Trolox
equivalents per sample amount (mg TEs)26.
Evaluation of total antioxidant capacity by phosphomolybdenum
assay
Test solution (0.3ml) was mixed with 3ml of reagent solution
(0.6M sulphuric acid, 28mM sodium phosphate and 4mM ammo-
nium molybdate). The sample absorbance was read at 695 nm
after 90-min incubation at 95 C. Results were expressed as milli-
moles of Trolox equivalents per sample amount (mmol TEs)27.
Reducing power assays
Cupric ion reducing (CUPRAC) method
Test solution (0.5ml) was added to reaction mixture containing
CuCl2 (1ml, 10mM), neocuproine (1ml, 7.5mM) and NH4Ac buffer
(1ml, 1M, pH 7.0). Similarly, a blank was prepared for each sample
(sample solution (0.5ml) and reaction mixture (3ml) without
CuCl2). Absorbance at 450 nm was read after 30-min incubation at
room temperature. Results were expressed as milligrams of Trolox
equivalents per sample amount (mg TEs)28.
Ferric reducing antioxidant power (FRAP) method
Sample solution (0.1ml) was added to FRAP reagent (2ml) con-
taining acetate buffer (0.3M, pH 3.6), 2,4,6-Tris(2-pyridyl)-s-triazine
(TPTZ) (10mM) in 40mM HCl and ferric chloride (20mM) in a ratio
of 10:1:1 (v/v/v). Then, the absorbance was read at 593 nm after
30-min incubation at room temperature. Results were expressed as
milligrams of Trolox equivalents per sample amount (mg TEs)29.
Metal chelating activity on ferrous ions
Test solution (2ml) was added to FeCl2 solution (0.05ml, 2mM).
The reaction was initiated by the addition of 5mM ferrozine
(0.2ml). Similarly, a blank was prepared for each sample (sample
solution (2ml), FeCl2 solution (0.05ml, 2mM) and water (0.2ml)).
Then, the absorbance of sample and blank was noted at 562 nm
after 10-min incubation at room temperature. Results were
expressed as milligrams of EDTA equivalents per sample amount
(EDTAEs)30.
Cell culture conditions and treatments of cells with NEs
HEp-2 laryngeal cancer cells were grown in MEM medium (Sigma),
supplemented with 1% penicillin–streptomycin and 10% foetal calf
serum (FCS) in a 5% CO2 atmosphere. Proliferation was evaluated
by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay as described27. Briefly, 96-well plates were seeded
with 5 103 cells/well and different amounts of Neem oil were
added to the cells, either as NEs (A2 sample) or as free oil. After
24-h exposure of the cells to the different preparations, 20ll of a
5mg/ml MTT solution in PBS was added to each well, and the
plates incubated for 3 h. After the formazan crystals were dissolved
by the addition 100 ll of dimethyl sulphoxide, optical density (OD)
at 570 nm was determined with a spectrophotometer/fluorimeter
microplate reader (PerkinElmer, Hopkinton, MA)31 and the values
measured for treated cells, compared to those of untreated
controls.
To visualise the uptake of NEs by HEp-2 cells, NEs loaded with
Nile red dye (NE-NR) were prepared. HEp-2 cells seeded on cover
slips into a 12-well plate were exposed to either NE-NR (10lL of
sample A1 NE-NR in 1ml of the cell culture medium) or to free NR
prepared as 1mg/mL stock solution in acetone and used at a final
concentration of 100 ng/mL. After 7- or 24-h incubation, cells were
washed with phosphate-buffered saline solution (PBS) and fixed in
methanol/acetone (1:1) for 5min at 20 C. After three washes,
coverslips were mounted on slides with 0.1% (w/v) p-phenylenedi-
amine in 10% (v/v) PBS, 90% (v/v) glycerol, pH 8.0 and the speci-
mens observed by fluorescence microscopy using a Leica DM4000
fluorescence microscope equipped with an FX 340 digital camera.
Statistical methods
Statistical significance of differences was evaluated by one-way
ANOVA with repeated measures followed by post hoc paired
Student’s t-test.
Results and discussion
The Neem oil nanoemulsions, prepared by adding the amphiphilic
substance (Tw20) at different weight ratio, were obtained by the
method previously described. The role of the surfactant in NE for-
mation is to facilitate the stabilisation process2,3. Typical examples
of aqueous soluble surfactants are nonionic surfactants (e.g. Tw20)
which are preferred because they are usually less irritating than
the ionic ones32.
The major feature of nanoemulsions is their great stability of
droplet suspension. Stability of an emulsion is hampered in two
ways: flocculation by coalescence and Ostwald ripening. In nanoe-
mulsion systems, flocculation is naturally prevented by steric sta-
bilisation, essentially due to the submicrometric droplet size. The
second one is the reduction of the configurational entropy which
occurs when interdroplet distance becomes lower than the
adsorbed layer thickness. In case of the second problem, stability
is dependent on the droplet radius r, the Hamaker constant A and
the adsorbed layer thickness d. The stability is very high if the d/r
value is high. In case of nanoemulsion droplets, d/r becomes
extremely high in comparison with macroemulsions, which com-
pletely prevents their capability to coagulate2.
The results reported in Table 1 for all NEs were part of the gen-
eral factorial design to establish the combination of variables and
their interactions yielding nanoemulsions with desirable properties
for nose-to-brain targeting. For each dependent variable (hydro-
dynamic diameter, PDI and f-potential), the effects corresponding
to the investigated factors (emulsifier amount and aqueous phase
type) and interactions were taken into account.
To stabilise the NE droplets and prevent the formation of
aggregates, NEs need to show an appropriate f-potential value
able to avoid droplet coalescence or fusion by repulsive, steric or
electrostatic effects33.
DLS measurements indicate that different surfactant ratios form
NEs with different but comparable sizes (Table 1), but in general,
it can be pointed out that increasing surfactant content, the
dimensions decrease. The dimensions of NEs in water or Hepes
buffer are the same for the same sample. Furthermore, all samples
show negative f-potential values (Table 1), indicative of the
absence of droplet aggregation. There is a significant difference in
f-potential values, if NEs have water or Hepes buffer as external
phase. This is probably due to the presence of salt and to the






























ion content. This content is greater in buffer solution, so in this
solution, ions will be able to adsorb on NE droplet surface and so
to increase f-potential absolute values.
As reported by -Dord-evic et al.34, at a given concentration of
surfactants in the formulation, more surfactant molecules are
expected to be adsorbed per unit area in case of larger droplets
leading to greater negative charge and, hence, more negative
f-potential values. It is obvious that all nanoemulsions prepared
with different aqueous phase types show different f-potential
values.
Apart from providing the hydrodynamic diameter and f-poten-
tial value, DLS provides also valuable information on the homo-
geneity of the suspension. A single sharp peak in the DLS profile
implies the existence of a single population of scattering particles.
The polydispersity index (PDI) values of NEs are reported in
Table 1: it is clear that all samples are homogenous and possess
NE population with limited dispersity (PDI< 0.3) and reduced
dimensions useful to carry out a nose-to-brain administration. For
the emerged reasons, only data related to samples with Hepes
buffer (102M pH 7.4) as external phase will be presented and dis-
cussed, although every experiment has been performed for all the
samples reported in Table 1.
In order to characterise the nature of the lipophilic shell, micro-
viscosity and polarity have been evaluated. Pyrene-loaded NEs
were prepared following the procedure described previously and
the fluorescence spectrum allowed calculating the values of polar-
ity and microviscosity reported in Table 1. Polarity and microvis-
cosity values are quite similar for all NEs; this is probably due to
the formation of the same shell and in particular of the same inner
structure independently from the surfactant amount used in the
preparation of NEs.
NEs stability is a complex issue and involves chemical, physical
and biological stability, which are all interrelated. The evaluation
of these parameters is fundamental to determine the potential in
vitro/in vivo applications in nanomedicine. The physical stability
studies of NEs are shown in Figure 1. From the analysis of
reported results, it is clear that all NE samples, stored at the two
different temperatures and prepared with the two different aque-
ous solutions, show high colloidal stability. In 90 days, dimension
and f-potential variations of all NE samples at the two different
temperatures show a similar trend, with no significant changes in
physical characteristics of the formulation. Stability studies per-
formed at 25 and 4 C show that all analysed samples are stable
for at least three months.
The effect of CSF on the stability of the NEs is another import-
ant aspect to take into account in order to evaluate and to under-
stand the behaviour of the vesicles when they are in contact with
fluids different from Hepes buffer. Experiments were performed at
37 C checking the size and f-potential of the droplets by DLS
analysis up to 3 h. During the time interval analysed, the same
trend is observed for all NEs. NEs in 45% CSF maintained their size
and f-potential values.
It can be concluded that in the presence of CSF, the selected
samples show a good stability, with no significant changes in
dimensions and f-potential values (Figure 2). X-ray scattering
experiments have been performed to characterise the structure
of nanoemulsions on the nanometre length scale. Figure 3
reports the SAXS intensity spectrum for A2. Structural features
are identifiable in different regions of the spectrum; at low q
(q< 0.1 nm1, large lengths), the intensity profile shows that
aggregates have a globular shape of finite size, of the order of
30 nm. At higher q values, in the region 0.18< q< 0.75 nm1, the
intensity as a function of q, I(q), is proportional to q1.66. This
decay behaviour, evidenced as a line of slope 1.66 in the
log–log scale of Figure 3, is characteristic of connected substruc-
tures or sponge phases, on distances between 8 and 30 nm.
Results show that the internal structure of the aggregates is not
a classical core-shell structure with well-defined interfaces
Figure 1. Shelf-life stability of evaluated NEs. Hydrodynamic diameter and f-potential values of different NEs (A–C) prepared using water1 or Hepes buffer2 as aqueous
phase up to 90 days stored at 25 and 4 C temperatures. Results are expressed as means ± SD (n¼ 3).






























between the oil region, the surfactant region and the water. The
oil phase is finely dispersed in nanosubstructures condensed by
Tween molecules in a 30 nm aggregate.
At lower oil content, the overall dimensions are quite smaller,
but with very similar internal structure (samples are less monodis-
perse). Similar oil substructures are confined in a smaller nano-
sized aggregate stabilised by a higher fraction of surfactant.
In order to investigate the morphology of the NEs, the
three Hepes samples (A2, B2 and C2) were investigated by TEM.
Figure 4 reveals that all nanoemulsion samples were almost spher-
ical in shape, similar to other nanoemulsions prepared with differ-
ent types of oil35. The TEM analyses confirm the presence of lipid
emulsion droplets with an internal structure characterised by the
presence of core with sponge-like features.
Starting from the promising biological activities of Neem oil,
we firstly analysed the effect of this natural product in terms of
antioxidant, reducing power and chelating properties. Pure Neem
oil was characterised by a high antioxidant effect as demonstrated
by a large number of assays with respect to reference compounds
such as Trolox and EDTA (Table 2). These results also suggest that
standardised Neem oil might be beneficial for the preparation of
nanoemulsion with putative pharmacological effects.
Moreover, the prepared nanoemulsions were subjected to the
same biological evaluation as regards their antioxidant, reducing
power and chelating properties. As shown in Table 3, antioxidant
activity (ABTS and DPPH tests) was strongly influenced by the
aqueous component, being Hepes buffer better than water. In the
other assays (CUPRAC, FRAP, phosphomolybdenum and chelating


































































Figure 2. Stability in CSF. Size and f-potential measurements by DLS of different NEs (A–C) prepared using water (A) and Hepes buffer 102M, pH 7.4 (B) at 37 C
















Figure 3. SAXS intensity spectrum. Scattered radiation intensity as a function of
momentum transfer q of A2 sample at room temperature. The flattening of the
intensity for q< 0.1 nm1 shows that aggregates have a globular shape of finite
size, of the order of 30 nm. At higher q (0.18< q< 0.75 nm1), the intensity I(q)/
q1.66. This decay behaviour is characteristic for an internal core composed by
connected substructures or sponge phases.
Figure 4. Transmission electron photomicrographs of the Hepes nanoemulsion
samples. Panel A: A2; Panel B: B2; Panel C: C2. Arrows indicate NE sizes corre-
sponding to DLS measures.
Table 2. Antioxidant and chelating properties of pure Neem oil.
Assay Resultsa
DPPH scavenging activity (mg TEs/g oil) 7.59 ± 0.07
ABTS scavenging activity (mg TEs/g oil) 14.78 ± 2.33
CUPRAC assay (mg TEs/g oil) 76.14 ± 5.57
FRAP assay (mg TEs/g oil) 51.13 ± 1.42
Phosphomolybdenum assay (mmol TEs/g oil) 0.77 ± 0.06
Metal chelating activity (mg EDTAEs/g oil) 19.26 ± 0.56
aValues expressed are means ± SD of three parallel measurements.
TE: Trolox equivalent; EDTAE: EDTA equivalent.






























significative difference between Hepes buffer and water. These bio-
logical results, in terms of Trolox or EDTA equivalents, were also
not modified by the decreasing content of loaded Neem oil
amount (from 9.2mg/mL for A/A1 to 2.6mg/mL for C/C1).
Collectively, these results could suggest not only a structural role,
but also a protective effect of Neem oil as a pivotal component for
the stability, conservation and microbial resistance of these
nanoemulsions.
It has been reported that bioactive compounds extracted from
Neem oil could affect multiple cellular pathways leading to apop-
totic cell death36. Moreover, in different tumour cell lines, Neem
oil has shown to exert anticancer activity via caspase-dependent
and independent apoptosis as well as autophagy-mediated cell
death37.
In order to use NEs as carriers of pharmacological active com-
pounds, we tested the effects of Neem-based NEs on the prolifer-
ation of tumour cell lines of different origin. Figure 5 illustrates
the results obtained from HEp-2 human laryngeal carcinoma cells,
treated for 24 h with increasing amounts of NEs. The bar graph
(Panel A) shows that the proliferation of cells exposed to 100lM
Neem oil complexed into NEs is significantly higher than that
detected in the samples treated with the same amount of free oil,
indicating that the toxic effect of this agent is reduced in our oil/
surfactant NE preparation.
To further evaluate the NEs as potential carriers of bioactive
substances, we assessed their cellular uptake by fluorescence
microscopy analysis of HEp-2 cells exposed for either 7 or 24 h to
Nile red-loaded NEs or Nile red dye alone. No signal could be
















A1 35.02 ± 0.47 22.72 ± 0.43 55.94 ± 2.28 61.90 ± 0.02 2.49 ± 0.02 39.34 ± 0.14
A2 53.06 ± 1.87 87.79 ± 9.87 55.51 ± 3.37 62.76 ± 0.97 2.91 ± 0.01 43.35 ± 0.05
B1 35.55 ± 0.24 30.52 ± 3.12 56.65 ± 0.73 60.99 ± 2.90 2.48 ± 0.07 38.49 ± 0.22
B2 46.71 ± 1.66 90.92 ± 8.64 59.91 ± 0.52 70.81 ± 12.76 2.33 ± 0.28 42.60 ± 0.22
C1 33.36 ± 0.19 15.75 ± 1.62 52.92 ± 0.14 56.69 ± 4.87 2.87 ± 0.09 40.38 ± 0.44
C2 49.02 ± 4.73 83.77 ± 3.10 50.73 ± 3.10 58.26 ± 1.85 5.54 ± 1.85 43.45 ± 0.02
Values expressed are means ± SD of three parallel measurements.
TE: Trolox equivalents; EDTAE: EDTA equivalents; Na: not active.
Figure 5. Exposure of HEp-2 cells to Neem oil-based NEs. HEp-2 cells were treated with NEs or free Neem oil as described (see Methods). The OD values obtained by
MTT assay for treated cells were converted into numbers of cells on a standard curve and expressed as percentages of untreated controls. Bars represent the mean of
three independent experiments ± SD. p< .05 (Panel A). Fluorescence microscopy images of HEp-2 control cells exposed to free Nile red (Panel B) and HEp-2 cells
exposed to Nile red-loaded NEs for 7 (Panel C) and 24 h (Panel D) obtained by fluorescence microscopy as described (see Methods). Scale bar: 10lm.






























detected in HEp-2 control cells exposed to free Nile red for 7 h
and similar results were obtained after 24 h (Panel B). In contrast,
a strong fluorescent intracellular signal, as a punctuated pattern
increasing with the time of incubation, could be visualised in the
cytoplasm of cells exposed to the NEs (Panel C: 7 h and Panel D:
24 h). Altogether, these data strongly suggest that our prepara-
tions might represent suitable systems to deliver bioactive
compounds into the cells.
Conclusion
This study confirms the possibility of preparing NEs by Tween 20
and Neem oil at different weight ratios. Among the different for-
mulation tested, the three (both in water and in Hepes buffer) pre-
pared and characterised in the present research paper show the
smallest hydrodynamic size and a homogenous sample size distri-
bution. The evaluation of the antioxidant activity of Neem oil
alone or as NEs confirms that the structured oil in NEs does not
lose its activity and is less cytotoxic than the free oil after inter-
action with HEp-2 cells. A future step will be to load a drug inside
NEs to enhance Neem oil antioxidant activity or to offer a double
therapeutic effect in the same formulation. This type of system
could be successfully applied in nose-to-brain delivery.
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